What Is Neonatal Abstinence Syndrome? Causes And Care

Neonatal abstinence syndrome (NAS) is a group of withdrawal symptoms that can appear in a newborn after exposure to certain drugs before birth. The most common cause is opioid exposure during pregnancy, though other medications and substances can also trigger it. Symptoms usually begin within the first few days of life and range from mild to severe. With proper monitoring and treatment, most affected babies recover fully.

What Is Neonatal Abstinence Syndrome Causes And Care?

NAS happens when a baby’s nervous system, which adapted to a drug while in the womb, reacts to the sudden absence of that drug after birth. Opioids are the best-known trigger, but the condition is not limited to them.

The word “abstinence” can be misleading. It does not mean the mother stopped using a substance. It describes the newborn’s withdrawal response. This is a physiological reaction, not a behavioral one, and it is not the parent’s fault.

Doctors sometimes use a broader term now: neonatal opioid withdrawal syndrome (NOWS), when opioids are the confirmed cause. NAS remains the umbrella term for withdrawal from any substance.

What Causes Neonatal Abstinence Syndrome?

The cause is exposure to a substance in the womb that the baby’s body becomes physically dependent on. When that exposure stops at birth, the baby’s system goes through withdrawal.

Opioids are the most common cause. This includes prescription pain relievers such as codeine, oxycodone, and hydrocodone, as well as illicit drugs like heroin. It also includes medications used to treat opioid use disorder, such as methadone and buprenorphine.

Other substances can cause withdrawal symptoms too. These include some antidepressants, benzodiazepines, and certain barbiturates. The symptoms and severity can differ depending on the substance.

One point worth clarifying: treating opioid use disorder with methadone or buprenorphine during pregnancy is considered safer for both mother and baby than untreated addiction. Untreated opioid use disorder carries serious risks, including relapse, overdose, and poor prenatal care. Babies exposed to these medications may develop NAS, but that risk is managed and does not mean the treatment should be stopped. Decisions about medication during pregnancy belong with an obstetrician and addiction specialist.

What Are the Symptoms of Neonatal Abstinence Syndrome?

Symptoms vary widely. Some babies show mild signs. Others need intensive care. The pattern depends on the substance, how much was used, how often, and how the baby’s body processes it.

Common signs affect the nervous system, digestion, and breathing. They can appear within 24 to 72 hours after birth for many opioids, though some medications can cause symptoms to start later, sometimes up to a week or more after birth.

• High-pitched or excessive crying
• Tremors or shaking
• Irritability and difficulty being soothed
• Poor feeding or trouble latching
• Vomiting or diarrhea
• Stuffy nose and sneezing
• Fast breathing
• Fever
• Trouble sleeping
• Tight muscle tone

Severity is not predictable from the mother’s dose alone. Two babies exposed to the same substance can have very different courses. This is one reason close monitoring matters more than assumptions about exposure.

How Is Neonatal Abstinence Syndrome Diagnosed?

There is no single blood test for NAS. Diagnosis is based on the baby’s history of exposure and a careful physical exam that tracks symptoms over time.

Doctors often use a scoring tool to rate symptoms and guide treatment. The most widely known is the Finnegan Neonatal Abstinence Scoring System, which assigns points to signs like crying, tremors, and feeding problems. Newer approaches sometimes focus on how well the baby is feeding, sleeping, and being comforted rather than relying only on a score.

Accurate diagnosis depends on honest information about prenatal substance exposure. Many hospitals screen for this routinely. A mother who discloses substance use is not reporting failure — she is giving the medical team what it needs to care for her baby safely.

Some hospitals test the baby’s first stool or urine to confirm exposure. These tests can detect certain substances for a period after birth, but they do not measure how severe withdrawal will be.

How Is Neonatal Abstinence Syndrome Treated?

Treatment depends on severity. Many babies need only supportive care. Others need medication to ease withdrawal safely.

Supportive care is the first step and often the main one. It includes:

• Frequent, smaller feedings to help with feeding problems
• A quiet, dimly lit environment to reduce stimulation
• Swaddling and gentle holding
• Skin-to-skin contact with a parent
• Keeping the baby calm and minimizing disruptions

Keeping mother and baby together, when safe, is now favored in many hospitals over separating them. Rooming-in and breastfeeding, when appropriate and medically cleared, can help some babies stay calmer. Breastfeeding decisions should be made with the medical team, because some substances pass into breast milk and some do not.

When symptoms are moderate to severe, medication may be needed. Morphine or methadone are commonly used to treat opioid withdrawal in newborns under close supervision. Other medications may be used depending on the substance involved. These are given in a hospital setting with careful monitoring and slowly reduced as symptoms improve.

Treatment length varies. Some babies improve within days. Others need weeks. There is no fixed timeline, and a slower course is not a sign of failure.

What Are the Risks and Long-Term Outcomes?

Most babies treated for NAS recover and go home healthy. The short-term risks are real, though. Severe withdrawal can cause dehydration from vomiting or diarrhea, poor weight gain, and breathing problems. These are why monitoring matters.

Long-term outcomes are less clear-cut. Some studies suggest children exposed to opioids before birth may have a higher chance of developmental or behavioral challenges. But separating the effect of the drug from other factors is difficult. Poverty, stress, limited prenatal care, and the home environment all influence a child’s development.

Research does not show that NAS itself guarantees lasting harm. Many children who had NAS as newborns develop typically. Early intervention and a stable, supportive home make a difference. Families can ask about developmental screening and early support programs.

Can Neonatal Abstinence Syndrome Be Prevented?

NAS can often be prevented or reduced when substance use during pregnancy is identified and managed early. The key is prenatal care, not blame.

Pregnant women who use opioids or other substances should tell their prenatal provider. This allows the medical team to plan monitoring and support before birth. Sudden, unsupervised stopping of opioids during pregnancy can be dangerous for both mother and baby, so any change in medication should be guided by a clinician.

For women with opioid use disorder, medication-assisted treatment is generally considered the safest path. It reduces the risk of relapse and overdose, which are far more dangerous to a pregnancy than managed withdrawal symptoms in the newborn.

Hospitals are increasingly using approaches that keep mothers and babies together and reduce unnecessary separation. This supports bonding and can improve outcomes for both.